ARMATA PHARMACEUTICALS, INC. Capital Expenditures
ARMATA PHARMACEUTICALS, INC. (ARMP) reported Capital Expenditures of $80.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-12
- ARMATA PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $17.00K, a 88.59% decline year-over-year.
- ARMATA PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $63.00K, a 36.36% decline year-over-year.
- ARMATA PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $52.00K.
- ARMATA PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $242.00K, a 28.82% decline year-over-year.
- ARMATA PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for fiscal 2025 was $542.00K, a 71.15% decline from fiscal 2024.
- ARMATA PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for fiscal 2024 was $1.88M, a 76.93% decline from fiscal 2023.
- ARMATA PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for fiscal 2023 was $8.14M, a 268.34% increase from fiscal 2022.
- ARMATA PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for fiscal 2022 was $2.21M, a 69.56% increase from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 3 month as first filed | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 6 month as first filed | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 9 month as first filed | Payments to Acquire Property, Plant, and Equipment 12 month | Payments to Acquire Property, Plant, and Equipment 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $17.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $80.00K 10-Q · filed 2026-08-12 | $132.00K derived: sum of 3 quarters · filed 2026-08-12 | $374.00K derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2026-03-31 | $63.00K 10-Q · filed 2026-05-13 | $115.00K derived: sum of 2 quarters · filed 2026-05-13 | $357.00K derived: sum of 3 quarters · filed 2026-05-13 | $506.00K derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-12-31 | $52.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $294.00K derived: sum of 2 quarters · filed 2026-03-25 | $443.00K derived: sum of 3 quarters · filed 2026-08-12 | $542.00K 10-K · filed 2026-03-25 | ||||
| 2025-09-30 | $242.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $391.00K derived: sum of 2 quarters · filed 2026-08-12 | $490.00K 10-Q · filed 2025-11-12 | $413.00K derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-06-30 | $149.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $248.00K 10-Q · filed 2026-08-12 | $171.00K derived: sum of 3 quarters · filed 2026-08-12 | $511.00K derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-03-31 | $99.00K 10-Q · filed 2026-05-13 | $22.00K derived: sum of 2 quarters · filed 2026-05-13 | $362.00K derived: sum of 3 quarters · filed 2026-05-13 | $1.73M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | -$77.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $263.00K derived: sum of 2 quarters · filed 2026-03-25 | $1.63M derived: sum of 3 quarters · filed 2026-03-25 | $1.88M 10-K · filed 2026-03-25 | ||||
| 2024-09-30 | $340.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $1.71M derived: sum of 2 quarters · filed 2025-11-12 | $1.96M 10-Q · filed 2025-11-12 | $4.36M derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | $1.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $1.62M 10-Q · filed 2025-08-12 | $4.02M derived: sum of 3 quarters · filed 2025-08-12 | $7.53M derived: sum of 4 quarters · filed 2025-08-12 | ||||
| 2024-03-31 | $250.00K 10-Q · filed 2025-05-14 | $2.65M derived: sum of 2 quarters · filed 2025-05-14 | $6.16M derived: sum of 3 quarters · filed 2025-05-14 | $6.38M derived: sum of 4 quarters · filed 2025-05-14 | ||||
| 2023-12-31 | $2.40M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | $5.91M derived: sum of 2 quarters · filed 2025-03-21 | $6.13M derived: sum of 3 quarters · filed 2025-03-21 | $8.14M 10-K · filed 2025-03-21 | ||||
| 2023-09-30 | $3.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $3.73M derived: sum of 2 quarters · filed 2024-11-13 | $5.74M 10-Q · filed 2024-11-13 | $5.29M derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | $222.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $2.23M 10-Q · filed 2024-08-13 | $1.78M derived: sum of 3 quarters · filed 2024-08-13 | $3.07M derived: sum of 4 quarters · filed 2024-08-13 | ||||
| 2023-03-31 | $2.01M 10-Q · filed 2024-05-07 | $1.55M derived: sum of 2 quarters · filed 2024-05-07 | $2.85M derived: sum of 3 quarters · filed 2024-05-07 | $3.98M derived: sum of 4 quarters · filed 2024-05-07 | ||||
| 2022-12-31 | -$455.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $839.00K derived: sum of 2 quarters · filed 2024-03-21 | $1.98M derived: sum of 3 quarters · filed 2024-03-21 | $2.21M 10-K · filed 2024-03-21 | ||||
| 2022-09-30 | $1.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $2.43M derived: sum of 2 quarters · filed 2023-11-14 | $2.67M 10-Q · filed 2023-11-14 | $2.89M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | $1.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $1.37M 10-Q · filed 2023-08-14 | $1.60M derived: sum of 3 quarters · filed 2023-08-14 | $2.18M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | $236.00K 10-Q · filed 2023-05-11 | $464.00K derived: sum of 2 quarters · filed 2023-05-11 | $1.05M derived: sum of 3 quarters · filed 2023-05-11 | $1.24M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | $228.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $810.00K derived: sum of 2 quarters · filed 2023-03-16 | $1.01M derived: sum of 3 quarters · filed 2023-03-16 | $1.30M 10-K · filed 2023-03-16 | ||||
| 2021-09-30 | $582.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $778.00K derived: sum of 2 quarters · filed 2022-11-09 | $1.08M 10-Q · filed 2022-11-09 | $1.44M derived: sum of 4 quarters · filed 2022-11-09 | ||||
| 2021-06-30 | $196.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $494.00K 10-Q · filed 2022-08-11 | $860.00K derived: sum of 3 quarters · filed 2022-08-11 | $941.00K derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | $298.00K 10-Q · filed 2022-05-12 | $664.00K derived: sum of 2 quarters · filed 2022-05-12 | $745.00K derived: sum of 3 quarters · filed 2022-05-12 | $1.02M derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | $366.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $447.00K derived: sum of 2 quarters · filed 2022-03-17 | $720.00K derived: sum of 3 quarters · filed 2022-03-17 | $824.00K 10-K · filed 2022-03-17 | ||||
| 2020-09-30 | $81.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $354.00K derived: sum of 2 quarters · filed 2021-11-10 | $458.00K 10-Q · filed 2021-11-10 | $479.00K derived: sum of 4 quarters · filed 2021-11-10 | ||||
| 2020-06-30 | $273.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $377.00K 10-Q · filed 2021-08-12 | $398.00K derived: sum of 3 quarters · filed 2021-08-12 | $333.00K derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | $104.00K 10-Q · filed 2021-05-13 | $125.00K derived: sum of 2 quarters · filed 2021-05-13 | $60.00K derived: sum of 3 quarters · filed 2021-05-13 | $186.00K derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | $21.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | -$44.00K derived: sum of 2 quarters · filed 2021-03-18 | $82.00K derived: sum of 3 quarters · filed 2021-03-18 | $224.00K 10-K · filed 2021-03-18 | ||||
| 2019-09-30 | -$65.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $61.00K derived: sum of 2 quarters · filed 2020-11-12 | $203.00K 10-Q · filed 2020-11-12 | $594.00K derived: sum of 4 quarters · filed 2020-11-12 | ||||
| 2019-06-30 | $126.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $268.00K 10-Q · filed 2020-08-13 | $659.00K derived: sum of 3 quarters · filed 2020-08-13 | $814.00K derived: sum of 4 quarters · filed 2020-08-13 | ||||
| 2019-03-31 | $142.00K 10-Q · filed 2020-05-14 | $7.00K 10-Q · filed 2019-05-06 | $533.00K derived: sum of 2 quarters · filed 2020-05-14 | $688.00K derived: sum of 3 quarters · filed 2020-05-14 | ||||
| 2018-12-31 | $391.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-19 | $546.00K derived: sum of 2 quarters · filed 2020-03-19 | $875.00K 10-K · filed 2020-03-19 | $44.00K 10-K · filed 2019-03-25 | ||||
| 2018-09-30 | $155.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $484.00K 10-Q · filed 2019-11-12 | $41.00K 10-Q · filed 2018-11-08 | |||||
| 2018-06-30 | $329.00K 10-Q · filed 2019-08-14 | $31.00K 10-Q · filed 2018-08-09 | ||||||
| 2017-12-31 | $18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-25 | $51.00K derived: sum of 2 quarters · filed 2019-03-25 | $53.00K derived: sum of 3 quarters · filed 2019-03-25 | $58.00K 10-K · filed 2019-03-25 | ||||
| 2017-09-30 | $33.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $35.00K derived: sum of 2 quarters · filed 2018-11-08 | $40.00K 10-Q · filed 2018-11-08 | $53.00K derived: sum of 4 quarters · filed 2018-11-08 | ||||
| 2017-06-30 | $2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $7.00K 10-Q · filed 2018-08-09 | $20.00K derived: sum of 3 quarters · filed 2018-08-09 | $49.00K derived: sum of 4 quarters · filed 2018-08-09 | ||||
| 2017-03-31 | $5.00K 10-Q · filed 2018-05-15 | $18.00K derived: sum of 2 quarters · filed 2018-05-15 | $47.00K derived: sum of 3 quarters · filed 2018-05-15 | $172.00K derived: sum of 4 quarters · filed 2018-05-15 | ||||
| 2016-12-31 | $13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $42.00K derived: sum of 2 quarters · filed 2018-03-14 | $167.00K derived: sum of 3 quarters · filed 2018-03-14 | $279.00K 10-K · filed 2018-03-14 | ||||
| 2016-09-30 | $29.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $154.00K derived: sum of 2 quarters · filed 2017-11-14 | $266.00K 10-Q · filed 2017-11-14 | $316.00K derived: sum of 4 quarters · filed 2017-11-14 | ||||
| 2016-06-30 | $125.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $237.00K 10-Q · filed 2017-08-14 | $287.00K derived: sum of 3 quarters · filed 2017-08-14 | $403.00K derived: sum of 4 quarters · filed 2017-08-14 | ||||
| 2016-03-31 | $112.00K 10-Q · filed 2017-05-15 | $162.00K derived: sum of 2 quarters · filed 2017-05-15 | $278.00K derived: sum of 3 quarters · filed 2017-05-15 | $287.00K derived: sum of 4 quarters · filed 2017-05-15 | ||||
| 2015-12-31 | $50.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-27 | $166.00K derived: sum of 2 quarters · filed 2017-03-27 | $175.00K derived: sum of 3 quarters · filed 2017-03-27 | $210.00K 10-K · filed 2017-03-27 | ||||
| 2015-09-30 | $116.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $125.00K derived: sum of 2 quarters · filed 2016-11-10 | $160.00K 10-Q · filed 2016-11-10 | $165.00K derived: sum of 4 quarters · filed 2016-11-10 | ||||
| 2015-06-30 | $9.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $44.00K 10-Q · filed 2016-08-15 | $49.00K derived: sum of 3 quarters · filed 2016-08-15 | $186.00K derived: sum of 4 quarters · filed 2016-08-15 | ||||
| 2015-03-31 | $35.00K 10-Q · filed 2016-05-12 | $40.00K derived: sum of 2 quarters · filed 2016-05-12 | $177.00K derived: sum of 3 quarters · filed 2016-05-12 | $1.01M derived: sum of 4 quarters · filed 2016-05-12 | ||||
| 2014-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $142.00K derived: sum of 2 quarters · filed 2016-03-30 | $973.00K derived: sum of 3 quarters · filed 2016-03-30 | $1.20M 10-K · filed 2016-03-30 | ||||
| 2014-09-30 | $137.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-16 | $968.00K derived: sum of 2 quarters · filed 2015-11-16 | $1.20M 10-Q · filed 2015-11-16 | $1.09M 10-Q · filed 2014-11-14 | $1.20M derived: sum of 4 quarters · filed 2015-11-16 | |||
| 2014-06-30 | $831.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | $1.06M 10-Q · filed 2015-08-13 | $1.06M derived: sum of 3 quarters · filed 2015-08-13 | $1.10M derived: sum of 4 quarters · filed 2015-08-13 | ||||
| 2014-03-31 | $229.00K 10-Q · filed 2015-05-15 | $234.00K derived: sum of 2 quarters · filed 2015-05-15 | $266.00K derived: sum of 3 quarters · filed 2015-05-15 | $331.00K derived: sum of 4 quarters · filed 2015-05-15 | ||||
| 2013-12-31 | $5.00K derived: 10-Q/A 12 month − 10-Q/A 9 month · filed 2015-04-15 | $37.00K derived: sum of 2 quarters · filed 2015-04-15 | $102.00K derived: sum of 3 quarters · filed 2015-04-15 | $102.00K 10-Q/A · filed 2015-04-15 | ||||
| 2013-09-30 | $32.00K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2015-04-15 | $97.00K derived: sum of 2 quarters · filed 2015-04-15 | $97.00K 10-Q/A · filed 2015-04-15 | |||||
| 2013-06-30 | $65.00K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2015-04-15 | $65.00K 10-Q/A · filed 2015-04-15 | ||||||
| 2013-03-31 | $0.00 10-Q/A · filed 2015-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |